待处理
入排:排除
图源:待检查
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.
Simron Singh, Diego Ferone, Jaume Capdevila, Jennifer Ang Chan, Wouter W de Herder, Daniel Halperin, Josh Mailman, Lisa Hellström, Hanna Liedman, Agneta Svedberg, Fredrik Tiberg
Trials 25(1) 297
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板